Total Voting Rights

1st May 2025 07:01

RNS Number : 6833G
Quadrise PLC
01 May 2025
 

1 May 2025

 

Quadrise plc

("Quadrise", "QED" or the "Company")

 

Total Voting Rights

 

In accordance with section 5.6.1 of the Financial Conduct Authority's (FCA) Disclosure Guidance and Transparency Rules (DTRs), the Company hereby notifies the market of the following:

 

The issued share capital of Quadrise as at 30 April 2025 consists of 1,986,695,465 ordinary shares of 1 pence each ("Ordinary Shares") with voting rights attached. Of these, no Ordinary Shares are held exclusive of voting rights in Treasury. Therefore, the total number of voting rights in Quadrise as at 30 April 2025 is 1,986,695,465.

 

Shareholders may use the figure of 1,986,695,465 Ordinary Shares as the denominator for the calculations by which they will determine if they are required to notify their interest, or a change to their interest, in Quadrise under the DTRs.

 

 

For further information please contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

 

 

Nominated Adviser

Cavendish Capital Markets Limited

 

 

+44 (0)20 7220 0500

Ben Jeynes

Katy Birkin

George Lawson

 

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate Broking)

 

 

+44 (0)20 3005 5000

 

Public & Investor Relations

 

Tavistock Communications

Simon Hudson

Nick Elwes

Ruairi Millar

 

 

+44 (0) 20 7920 3150

 

 

About Quadrise

Quadrise is the supplier of MSAR® and bioMSAR™ emulsion technology, fuels and biofuels, providing innovative solutions to lower energy costs, pollution and greenhouse gas emissions today for the global power generation, shipping, industrial and oil industries.

Learn more at: www.quadrise.com

 

Follow us on social media:

LinkedIn: @Quadrise Plc

X: @QuadrisePlc

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRUKAVRVSUSUAR